You are here

Article info

Article menu
Download PDFPDF
Editorial
Natriuretic peptide should be used as a routine tool for evaluation of patients with atrial fibrillation

Authors

  • Ziad Hijazi Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden PubMed articlesGoogle scholar articles
  • Lars Wallentin Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Ziad Hijazi, Cardiology, Department of Medical Sciences, Uppsala University, Uppsala 752 37, Sweden; ziad.hijazi{at}ucr.uu.se
View Full Text

Citation

Hijazi Z, Wallentin L
Natriuretic peptide should be used as a routine tool for evaluation of patients with atrial fibrillation
Heart 2019;105:353-354.

Publication history

  • First published October 12, 2018.
Online issue publication 
January 18, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.